Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The effectiveness of maternal immunization in preventing infant pertussis was first demonstrated in England, 1 year after the program using diphtheria-tetanus-5-component acellular pertussis-inactivated polio vaccine (dT5aP-IPV) was introduced in 2012. Vaccine effectiveness against laboratory-confirmed pertussis has been sustained >90% in the 3 years following its introduction, despite changing to another acellular vaccine with different antigen composition. Consistent with this, disease incidence in infants <3 months of age has remained low despite high activity persisting in those aged 1 year and older. Vaccine effectiveness against infant deaths was estimated at 95% (95% confidence interval, 79%-100%). Additional protection from maternal immunization is retained in infants who received their first dose of the primary series. There is no longer evidence of additional protection from maternal vaccination after the third infant dose. Although numbers are small and ongoing assessment is required, there is no evidence of increased risk of disease after primary immunization in infants whose mothers received maternal vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Maternal vaccination with a pertussis-containing vaccine is now routinely recommended in several countries and has been shown to be safe and to result in high concentrations of antibody in the infant over the first 2 months of life (18–21).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of maternal pertussis vaccination in England: an observational study
Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60686-3 · Cited by 739 · cited 6×
“matched to the general practice of the cases [10, 11].”
BackgroundMethodInfluentialSelf-citationSawyer, M., Liang, J. L., Messonnier, N. E., & Clark, T. A. (2013) · MMWR Morbidity and Mortality Weekly Report · Cited by 722
Munoz, F. M., Bond, N. H., Maccato, M., Pinell, P., Hammill, H. A., Swamy, G. K., Walter, E. B., Jackson, L. A., Englund, J. A., Edwards, M. S., et al. (2014) · JAMA · doi:10.1001/jama.2014.3633 · Cited by 489
Dabrera, G., Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Fry, N. K., & Ramsay, M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu821 · Cited by 385 · cited 3×
“ceived vaccine at least 1 week prior to delivery, using both the screening method and case-control study approaches [10, 11], and this level of protection appears to have been sustained in the 3 years following the introduction of the program despite”
BackgroundMethodSelf-citationSafety of pertussis vaccination in pregnant women in UK: observational study
Donegan, K., King, B., & Bryan, P. (2014) · BMJ · doi:10.1136/bmj.g4219 · Cited by 281 · cited 1×
“servational study in the United Kingdom, which did not identify an increased risk for a range of maternal, fetal, and neonatal outcomes among almost 18 000 vaccinated pregnant women and their infants [12].”
BackgroundEstimation of Vaccine Effectiveness Using the Screening Method
FARRINGTON, C. P. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.4.742 · Cited by 261 · cited 1×
“Detailed methods have been previously described [10, 19].”
Eberhardt, C. S., Blanchard-Rohner, G., Lemaître, B., Boukrid, M., Combescure, C., Othenin-Girard, V., Chilin, A., Petre, J., de Tejada, B. M., & Siegrist, C.-A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw027 · Cited by 253
Bogoch, I. I., Creatore, M. I., Cetron, M. S., Brownstein, J. S., Pesik, N., Miniota, J., Tam, T., Hu, W., Nicolucci, A., Ahmed, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61828-6 · Cited by 235
Research works printed but not linked: 1
- Maertens, 2015, Pertussis vaccination of pregnant women: rationale for the actual recommendations in Belgium, Tijdschrift Voor Geneeskunde, 71, 497
Cited by
Liang, J. L., Tiwari, T., Moro, P., Messonnier, N. E., Reingold, A., Sawyer, M., & Clark, T. A. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6702a1 · Cited by 457
Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis
Baxter, R., Bartlett, J., Fireman, B., Lewis, E., & Klein, N. P. (2017) · Pediatrics · doi:10.1542/peds.2016-4091 · Cited by 254
Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review
Vygen-Bonnet, S., Hellenbrand, W., Garbe, E., von Kries, R., Bogdan, C., Heininger, U., Röbl-Mathieu, M., & Harder, T. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4824-3 · Cited by 178
“Five [16, 43, 45, 47, 49] of the eight studies were judged as having a serious RoB, while three studies had a moderate RoB [44, 46, 48].”
BackgroundResultInfluentialWilcox, C. R., Holder, B., & Jones, C. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01294 · Cited by 200
Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors
Clements, T., Rice, T. F., Vamvakas, G., Barnett, S., Barnes, M., Donaldson, B., Jones, C. E., Kampmann, B., & Holder, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01920 · Cited by 163
Skoff, T. H., Blain, A. E., Watt, J., Scherzinger, K., McMahon, M., Zansky, S. M., Kudish, K., Cieslak, P. R., Lewis, M., Shang, N., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix724 · Cited by 173
“Three years postintroduction, high effectiveness has been sustained [13].”
BackgroundMaternal vaccination: a review of current evidence and recommendations
Etti, M., Calvert, A., Galiza, E. P., Lim, S., Khalil, A. A., Doaré, K. L., & Heath, P. T. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.10.041 · Cited by 182
Necrotizing pneumonia: an emerging problem in children?
Masters, I. B., Isles, A. F., & Grimwood, K. (2017) · Pneumonia · doi:10.1186/s41479-017-0035-0 · Cited by 177
“Maternal antenatal immunization with pertussis and influenza provide early protection in very young infants and are gaining wider acceptance [119, 120] , while novel RSV vaccines administered during pregnancy and to older infants are also being evaluated [121] .”
BackgroundKandeil, W., van den Ende, C., Bunge, E. M., Jenkins, V. A., Ceregido, M. A., & Guignard, A. P. (2020) · Expert Review of Vaccines · doi:10.1080/14760584.2020.1791092 · Cited by 156
Maternal immunization: where are we now and how to move forward?
Vojtek, I., Dieussaert, I., Doherty, T. M., Franck, V., Hanssens, L., Miller, J. M., Bekkat-Berkani, R., Kandeil, W., Prado-Cohrs, D., & Vyse, A. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1421320 · Cited by 149
Pertussis vaccines and protective immunity
Kapil, P., & Merkel, T. J. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.03.006 · Cited by 124
Halperin, S. A., Langley, J. M., Ye, L., MacKinnon‐Cameron, D., ElSherif, M. S., Allen, V. M., Smith, B. R., Halperin, B. A., McNeil, S., Vanderkooi, O. G., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy244 · Cited by 121
“There is accumulating evidence from England and Wales [34, 35] and the United States [36] that maternal immunization with Tdap is effective in preventing pertussis in newborn infants.”
BackgroundPertussis vaccines, epidemiology and evolution
de Cellès, M. D., & Rohani, P. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01064-8 · Cited by 120
“On the other hand, epidemiological studies have provided mixed evidence about the relative risk of pertussis after primary vaccination in infants born to vaccinated mothers versus unvaccinated mothers, with no indication of blunting in some studies and suggestion of it in others 140,142,143 .”
Barug, D., Pronk, I., van Houten, M. A., Versteegh, F. G. A., Knol, M. J., van de Kassteele, J., Berbers, G. A. M., Sanders, E. A. M., & Rots, N. Y. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30717-5 · Cited by 113
Review of vaccination in pregnancy to prevent pertussis in early infancy
Campbell, H., Gupta, S. K., Dolan, G. P., Kapadia, S. J., Singh, A. K., Andrews, N. J., & Amirthalingam, G. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000829 · Cited by 111
Self-citationSaul, N., Wang, K., Bag, S. K., Baldwin, H., Alexander, K., Chandra, M., Thomas, J. H., Quinn, H., Sheppeard, V. K., & Conaty, S. J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.047 · Cited by 98
Macina, D., & Evans, K. E. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00520-9 · Cited by 91
“%) reported cases \ 1 month: 101 (1) 1–3 months: 386 (4) 4–11 months: 146 (2) 1–9 years: 894 (10) C 10 years: 7616 (83 UK, England [68] Population-based, national surveillance January 2013 to December 2015 All ages Notified cases PCR, culture Incidence/100,000 2012: 17.6 2013: 8.6 2014: 6.2 2015: 7.7 Table 2 continued…”
BackgroundInfluentialPERISCOPE: road towards effective control of pertussis
Diavatopoulos, D. A., Mills, K. H. G., Kester, K. E., Kampmann, B., Silerova, M., Heininger, U., van Dongen, J. J. M., der Most, R. G. V., Huynen, M. A., Siena, E., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30646-7 · Cited by 92
Eberhardt, C. S., Rohner, G. B., Lemaître, B., Combescure, C., Othenin‐Girard, V., Chilin, A., Pétré, J., de Tejada, B. M., & Siegrist, C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix046 · Cited by 85
“Neonatal pertussis remains an important public health concern, and maternal vaccination is the sole way to protect this fragile population from complications and death [1].”
BackgroundFuruta, M., Sin, J., Ng, E. S. W., & Wang, K. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1559-2 · Cited by 98
“Although, little is known regarding whether or to what extent the increased antibody concentrations transferred through the placenta have a protection effect for pertussis in neonates, vaccine effectiveness based on UK observational data is estimated to be around 90% [16, 43], possibly as a result of both passive anti…”
BackgroundThe Protective Role of Maternal Immunization in Early Life
Cinicola, B. L., Conti, M. G., Terrin, G., Sgrulletti, M., Elfeky, R., Carsetti, R., Salinas, A. F., Mortari, E. P., Brindisi, G., Curtis, M. D., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.638871 · Cited by 91
“In addition, no evidence of a clinically significant effect of blunting has been found in the United States (US) and the United Kingdom (UK), where maternal Tdap vaccination has been implemented since 2011 (US) and 2012 (UK) (78, 79).”
BackgroundEstimating the full public health value of vaccination
Gessner, B. D., Kaslow, D. C., Louis, J. A., Neuzil, K. M., O’Brien, K. L., Picot, V., Pang, T., Parashar, U. D., Saadatian‐Elahi, M., & Nelson, C. B. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.048 · Cited by 88
Vaccination during pregnancy: current and possible future recommendations
Maertens, K., Orije, M. R. P., Damme, P. V., & Leuridan, E. E. (2020) · European Journal of Pediatrics · doi:10.1007/s00431-019-03563-w · Cited by 81
Maisa, A., Milligan, S., Quinn, A., Boulter, D., Johnston, J., Treanor, C., & Bradley, D. (2018) · Public Health · doi:10.1016/j.puhe.2018.05.025 · Cited by 80
Impact of the COVID-19 pandemic on Bordetella pertussis infections in England
Tessier, E., Campbell, H., Ribeiro, S., Rai, Y., Burton, S., Roy, P., Fry, N. K., Litt, D. J., & Amirthalingam, G. (2022) · BMC Public Health · doi:10.1186/s12889-022-12830-9 · Cited by 82
“All laboratory-confirmed cases are followed up with the patients’ general practitioner (GP) to collect clinical and epidemiological data including vaccination history and, for infants born after 1 October 2012, maternal vaccination status [6, 18].”
BackgroundMethodSelf-citationWang, S., Zhang, S., & Liu, J. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2513729 · Cited by 72
“34 41–43 However, some studies have found that the cyclical nature of pertussis is not as pronounced in certain areas of the United States 37 and China.”
Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review
Switzer, C., D’Heilly, C., & Macina, D. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-00264-7 · Cited by 67
Acellular Pertussis Vaccine Components: Today and Tomorrow
Dewan, K. K., Linz, B., DeRocco, S. E., & Harvill, E. T. (2020) · Vaccines · doi:10.3390/vaccines8020217 · Cited by 66
“An effectiveness study conducted in infants in the UK found that a 5-component aP vaccine performed as well as a highly effective wP vaccine [55] and a low-dose, 5-component aP vaccine used in the UK to immunize during pregnancy provided >90% effectiveness against laboratory-confirmed pertussis in infants <3 months of…”
BackgroundInfluentialSkoff, T. H., Deng, L., Bozio, C. H., & Hariri, S. (2023) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2022.5689 · Cited by 60
Giles, M. L., Buttery, J., Davey, M.-A., & Wallace, E. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.084 · Cited by 56
Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.
Bombardieri, E., Seregni, E. C., Villano, C., Chiti, A., & Bajetta, E. (2004) · PubMed · Cited by 56
Abu-Raya, B., Forsyth, K. D., Halperin, S. A., Maertens, K., Jones, C. E., Heininger, U., Hozbor, D. F., von König, C. H. W., Chitkara, A. J., Muloiwa, R., et al. (2022) · Vaccines · doi:10.3390/vaccines10121990 · Cited by 60
“While immunogenicity data could suggest that infants of women vaccinated against pertussis in pregnancy might be at increased risk for pertussis later in childhood, surveillance data from the UK have not demonstrated an increase in pertussis cases in toddlers (1–4 years of age) after the introduction of the vaccinatio…”
BackgroundFu, X., Ying, Q., Zeng, T., Long, T., & Wang, Y. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.019 · Cited by 54
Forsyth, K. D., Tan, T. Q., von König, C. H. W., Heininger, U., Chitkara, A. J., & Plotkin, S. A. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.10.028 · Cited by 53
Maternal Immunization: Nature Meets Nurture
Saso, A., & Kampmann, B. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01499 · Cited by 58
Placental transfer of antibody and its relationship to vaccination in pregnancy
Calvert, A., & Jones, C. E. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000372 · Cited by 56
Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015–2017
Rowe, S. L., Perrett, K. P., Morey, R., Stephens, N., Cowie, B. C., Nolan, T. M., Leder, K. S., Pitcher, H. C., Sutton, B. A., & Cheng, A. C. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50125 · Cited by 52
Safety of Maternal Immunization Against Pertussis: A Systematic Review
D’Heilly, C., Switzer, C., & Macina, D. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-00265-6 · Cited by 57
Macina, D., & Evans, K. E. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00440-8 · Cited by 52
Christophi, C. A., Sotos‐Prieto, M., Lan, F., Delgado-Velandía, M., Efthymiou, V., Gaviola, G. C., Hadjivasilis, A., Hsu, Y., Kyprianou, A., Lidoriki, I., et al. (2020) · Scientific Reports · doi:10.1038/s41598-021-87803-w · Cited by 51
Gopal, D. P., Barber, J., & Toeg, D. (2019) · BMJ · doi:10.1136/bmj.l401 · Cited by 56
Current Challenges and Achievements in Maternal Immunization Research
Muñoz, F. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00436 · Cited by 49
Krishnaswamy, S., Lambach, P., & Giles, M. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1564433 · Cited by 53
Laris-González, A., Bernal-Serrano, D., Jarde, A., & Kampmann, B. (2020) · Vaccines · doi:10.3390/vaccines8010124 · Cited by 48
Abu-Raya, B., Maertens, K., Muñoz, F. M., Zimmermann, P., Curtis, N. C., Halperin, S. A., Rots, N. Y., Barug, D., Holder, B. S., Kampmann, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.689394 · Cited by 48
“2 per 100,000 in infants 1-4 years of age (33).”
Briga, M., Goult, E., Brett, T. S., Rohani, P., & de Cellès, M. D. (2024) · Nature Communications · doi:10.1038/s41467-024-44943-7 · Cited by 50
“…immunization may prevent mothers from transmitting pertussis to their infants, an indirect effect that could lead to underestimating the risk of pertussis and masking the effect of blunting in the group of infants vaccinated and born to vaccinated mothers (as recognized by some investigators 13 ).”
Beran, J., Lickliter, J. D., Schwarz, T. F., Johnson, C., Chu, L., Domachowske, J. B., Damme, P. V., Withanage, K., Fissette, L. A., David, M., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy065 · Cited by 46
Wood, N., Nolan, T. M., Marshall, H. S., Richmond, P., Gibbs, E., Perrett, K. P., & McIntyre, P. B. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.2349 · Cited by 43
Abu-Raya, B., Giles, M., Kollmann, T. R., & Sadarangani, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02423 · Cited by 44
“Furthermore, data to define the preferred timing of vaccination against pertussis within the third trimester are limited and inconclusive (13, 15).”
BackgroundWalker, J. L., Rentsch, C. T., McDonald, H. I., Bak, J., Minassian, C., Amirthalingam, G., Edelstein, M. L., & Thomas, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046545 · Cited by 43
Self-citationOguti, B., Ali, A., Andrews, N. J., Barug, D., Dang, D. A., Halperin, S. A., Hoang, H. T. T., Holder, B. S., Kampmann, B., Kazi, A. M., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.12.007 · Cited by 45
“These have been successful in reducing infant mortality, most markedly with maternal pertussis immunisation; a UK study estimated maternal pertussis vaccine effectiveness against infant mortality to be 95%, three years after the national program was implemented [13].”
BackgroundSelf-citationScheltema, N. M., Kavelaars, X., Thorburn, K., Hennus, M. P., van Woensel, J. B. M., van der Ent, C. K., Borghans, J. A. M., Bont, L., & Drylewicz, J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.021 · Cited by 42
“When we considered a vaccine coverage of 60%, based on the observed vaccine coverage for maternal pertussis vaccination in the United Kingdom and Belgium [40,41], the percentage of prevented cases would be substantially lower (e.g. 42–48% and 50–54% instead of 62–75% and 76–87% of RSV-related PICU admissions in the Un…”
The effect of maternal antibodies on the cellular immune response after infant vaccination: A review
Orije, M. R. P., Maertens, K., Corbière, V., Wanlapakorn, N., Damme, P. V., Leuridan, E. E., & Mascart, F. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.025 · Cited by 45
“Together with the growing evidence that blunting maybe short-lived and longer-term protection is not compromised after active immunization in infants, these results imply that there might be no clinical impact of humoral blunting [53,54].”
BackgroundPitisuttithum, P., Chokephaibulkit, K., Sirivichayakul, C., Sricharoenchai, S., Dhitavat, J., Pitisuthitham, A., Phongsamart, W., Boonnak, K., Lapphra, K., Sabmee, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30375-x · Cited by 41
Macina, D., & Evans, K. E. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00439-1 · Cited by 41
Merdrignac, L., Acosta, L. M., Habington, A., Cenoz, M. G., Pandolfi, E., Fabianova, K., Jordán, I., O’Sullivan, N., Navasués, A., Tozzi, A. E., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.09.054 · Cited by 42
Pertussis Epidemiology in Children: The Role of Maternal Immunization
Principi, N., Bianchini, S., & Esposito, S. (2024) · Vaccines · doi:10.3390/vaccines12091030 · Cited by 42
“[27].”
BackgroundAmirthalingam, G., Campbell, H., Ribeiro, S., Stowe, J., Tessier, E., Litt, D. J., Fry, N. K., & Andrews, N. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac651 · Cited by 46
Self-citationPertussis and influenza immunisation coverage of pregnant women in New Zealand
Howe, A. S., Pointon, L., Gauld, N. J., Paynter, J., Willing, E. J., & Turner, N. M. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.08.030 · Cited by 38
Byrne, L., Campbell, H., Andrews, N. J., Ribeiro, S., & Amirthalingam, G. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-311802 · Cited by 41
Self-citationMaternal Vaccination and Infant Influenza and Pertussis
Rowe, S. L., Leder, K. S., Perrett, K. P., Romero, N., Nolan, T. M., Stephens, N., Cowie, B. C., & Cheng, A. C. (2021) · PEDIATRICS · doi:10.1542/peds.2021-051076 · Cited by 39
Damron, F. H., Barbier, M., Dubey, P., Edwards, K. M., Gu, X., Klein, N. P., Lu, K. T., Mills, K. H. G., Pasetti, M. F., Read, R. C., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000676 · Cited by 38
Röbl-Mathieu, M., Kunstein, A., Liese, J. G., Mertens, T., & Wojcinski, M. (2021) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2021.0020 · Cited by 47
Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies
Ye, S., Ma, S., Zhou, Q., & Xu, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1618883 · Cited by 35
Australian vaccine preventable disease epidemiological review series: Pertussis, 2013–2018
Marshall, K. S., Quinn, H., Pillsbury, A., Maguire, J., Lucas, R. M., Dey, A., Beard, F. H., Macartney, K. K., & McIntyre, P. B. (2022) · Communicable Diseases Intelligence · doi:10.33321/cdi.2022.46.3 · Cited by 37
Leroux-Roels, G. G., Boever, F. D., Maes, C., Nguyên, T. L.-A., Baker, S. A., & Lopez, A. G. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.011 · Cited by 34
Böhm, S., Röbl-Mathieu, M., Scheele, B., Wojcinski, M., Wichmann, O., & Hellenbrand, W. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4437-y · Cited by 35
Tessier, E., Campbell, H., Ribeiro, S., Fry, N. K., Brown, C. S., Stowe, J., Andrews, N. J., Ramsay, M. E., & Amirthalingam, G. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa836 · Cited by 37
Self-citationLiu, C., Yang, L., Cheng, Y., Xu, H., & Xu, F. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05535-0 · Cited by 33
Maternal RSV vaccine development. Where to from here?
Gunatilaka, A., & Giles, M. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1955608 · Cited by 33
Neonatal Immunity toBordetella pertussisInfection and Current Prevention Strategies
Correia, C. A., Rodrigues, A. K. S., & de Brito, C. A. (2019) · Journal of Immunology Research · doi:10.1155/2019/7134168 · Cited by 38
Falkingham, J., Evandrou, M., Qin, M., & Vlachantoni, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2021-053094 · Cited by 37
Maternal immunisation: What have been the gains? Where are the gaps? What does the future hold?
Giles, M., Krishnaswamy, S., & Wallace, E. M. (2018) · F1000Research · doi:10.12688/f1000research.15475.1 · Cited by 37
Perrett, K. P., Halperin, S. A., Nolan, T. M., Martínez, A. C., Martinón‐Torres, F., García-Sicilia, J., Virta, M., Vanderkooi, O. G., Zuccotti, G., Manzoni, P., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.104 · Cited by 32
“To date, there is no evidence that the observed immunological interference is of clinical significance as there has been no increase in pertussis disease in infants born to Tdap-vaccinated mothers following primary series vaccinations in the first year of life [13,14,39].”
BackgroundKandeil, W., Savić, M., Ceregido, M. A., Guignard, A. P., Kuznetsova, A., & Mukherjee, P. (2020) · Expert Review of Vaccines · doi:10.1080/14760584.2020.1749597 · Cited by 31
“One study in the UK evaluated vaccine effectiveness (VE) of maternal Tdap immunization against infant pertussis disease following primary infant immunization with the screening method in children up to 23 months of age and found an effectiveness of 82% (95% CI: 65–91%) in infants after the first primary dose of DTaP,…”
BackgroundFactors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal
Johm, P., Nkoum, N., Ceesay, A., Mbaye, E. H. S., Larson, H. J., & Kampmann, B. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.05.068 · Cited by 32
Ralph, K. M. I., Dorey, R. B., Rowe, R., & Jones, C. E. (2021) · Midwifery · doi:10.1016/j.midw.2021.103222 · Cited by 32
Macina, D., & Evans, K. E. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00442-6 · Cited by 29
Hunagund, S., Golan, Y., Asiodu, I. V., Prahl, M. K., & Gaw, S. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.910383 · Cited by 30
Review of maternal immunisation during pregnancy: focus on pertussis and influenza
Rohner, G. B., & Eberhardt, C. S. (2017) · Swiss Medical Weekly · doi:10.4414/smw.2017.14526 · Cited by 35
Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015–2017
Rowe, S. L., Leder, K. S., & Cheng, A. C. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50386 · Cited by 28
Timing of pertussis vaccination during pregnancy: Evidence and implementation – A systematic review
Weerdt, L. D., Herzog, S. A., Damme, P. V., & Maertens, K. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.07.053 · Cited by 28
Chong, C.-Y., Yung, C.-F., Tan, N. W., Acharyya, S., & Thoon, K. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.085 · Cited by 30
Controlling pertussis: how can we do it? A focus on immunization
Martinón‐Torres, F., Heininger, U., Thomson, A., & von König, C. H. W. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1445530 · Cited by 28
“reduced to 43% [69], highlighting the importance of the”
BackgroundSchwarz, T. F., McPhee, R. A., Launay, O., Leroux-Roels, G. G., Talli, J., Picciolato, M., Gao, F., Cai, R., Nguyên, T. L.-A., Dieussaert, I., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz395 · Cited by 28
Carrasquilla, G., Porras, A., Martínez, S., DeAntonio, R., Devadiga, R., Cáceres, D. C., & Juliao, P. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.07.046 · Cited by 27
Pitisuttithum, P., Dhitavat, J., Sirivichayakul, C., Pitisuthitham, A., Sabmee, Y., Chinwangso, P., Kerdsomboon, C., Fortuna, L., Spiegel, J., Chauhan, M., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100976 · Cited by 24
Sánchez‐González, G., Luna-Casas, G., Mascareñas, C., Macina, D., & Vargas-Zambrano, J. C. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.08.046 · Cited by 24
Bordetella pertussis isolates vary in their interactions with human complement components
Brookes, C., Freire-Martin, I., Cavell, B. E., Alexander, F., Taylor, S. C., Persaud, R., Fry, N. K., Preston, A., Diavatopoulos, D. A., & GORRINGE, A. R. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0084-3 · Cited by 24
Self-citationJones, C. E., Calvert, A., Southern, J., Matheson, M., Andrews, N. J., Khalil, A. A., Cuthbertson, H., Hallis, B., England, A., Heath, P. T., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02005-5 · Cited by 26
Self-citationThe immunogenicity and safety of Group B Streptococcal maternal vaccines: A systematic review
Bjerkhaug, A. U., Ramalingham, S., Mboizi, R. B., Doaré, K. L., & Klingenberg, C. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.11.056 · Cited by 24
Adherence and Concordance of Influenza and Pertussis Vaccination Coverage in Pregnant Women in Spain
Rodríguez-Blanco, N., Tuells, J., Vila‐Candel, R., & Nolasco, A. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16040543 · Cited by 23
Pertussis in Latin America and the Hispanic Caribbean: a systematic review
de Gentile, A. S., Bricks, L. F., Avila-Aguero, M. L., Kfouri, R. D. Á., Torres, J. P., Ulloa‐Gutiérrez, R., Glover, R. E., & Sarti, E. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1643241 · Cited by 23
“conjugated antigens [200], and thereby lead to decreased protection do not appear to be warranted [201, 202].”
BackgroundImmunization During Pregnancy: Impact on the Infant
Perrett, K. P., & Nolan, T. M. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0231-7 · Cited by 26
“Vaccine effectiveness did not differ significantly by vaccine product (dT5aP-IPV and dT3aP-IPV) and, importantly, despite a number of studies demonstrating variable blunting of pertussis responses and other antigens in the routine program in infants born to vaccinated mothers [90, 95, 97, 98], there was no evidence of…”
BackgroundInfluentialNo. 357-Immunization in Pregnancy
Castillo, E., & Poliquin, V. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.11.010 · Cited by 25
Godongwana, M., Myburgh, N., Adedini, S. A., Cutland, C., & Radebe, N. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05926 · Cited by 24
“Studies conducted in the UK, US and Spain have confirmed more than 90% effectiveness of maternal pertussis vaccination in preventing pertussis infection among infants 12 weeks and younger (Baxter et al., 2017; Bellido-Blasco et al., 2017; Dabrera et al., 2015; Amirthalingam et al., 2016).”
BackgroundFunctional and structural modifications of influenza antibodies during pregnancy
Jennewein, M. F., Košíková, M., Noelette, F. J., Radvák, P., Boudreau, C. M., Campbell, J. D., Chen, W. H., Xie, H., Alter, G., & Pasetti, M. F. (2022) · iScience · doi:10.1016/j.isci.2022.104088 · Cited by 21
“In the past decade, the introduction of maternal acellular pertussis vaccine (ACIP, 2013) propitiously reduced infant hospitalizations and respiratory infections (Steinhoff et al., 2017; Amirthalingam et al., 2016).”
BackgroundMoschese, V., Angelis, L. D., Capogna, M. V., Graziani, S., Baglivo, F., Pietropolli, A., del Giudice, M. M., & Rizzo, C. (2023) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2023.1237064 · Cited by 21
Calvert, A., Amirthalingam, G., Andrews, N. J., Basude, S., Coleman, M., Cuthbertson, H., England, A., Greening, V., Hallis, B., Johnstone, E., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00332-9 · Cited by 28
Self-citationCamillo, C. D., Vittucci, A. C., Antilici, L., Ciarlitto, C., Linardos, G., Concato, C., Lancella, L., & Villani, A. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1791617 · Cited by 22
“tion program has also been supported by the findings of a large observational study in the United Kingdom, which did not identify an increased risk for a range of maternal, fetal, and neonatal outcomes.(54) In 2011, ACIP recommended the combined Tdap vaccination in the third trimester of pregnancy for women who had ne…”
Result
Metadata
- Authors
- Amirthalingam, G., Campbell, H., Ribeiro, S., Fry, N. K., Ramsay, M., Miller, E., & Andrews, N.
- Affiliations
- Public Health England (GB)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-12
- Volume
- 63
- Issue
- suppl 4
- Pages
- S236-S243
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5106626
- OpenAlex
- W2554060857
- Cited by
- 275
- References
- 20
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 10 · 2023: 23 · 2022: 21 · 2021: 54 · 2020: 38 · 2019: 34 · 2018: 39 · 2017: 26
- FWCI
- 33.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Funders
- Public Health England
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Diphtheria, Corynebacterium, and Tetanus
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- acellular pertussis vaccine, vaccine effectiveness, infant pertussis prevention, infant mortality, vaccine safety, disease incidence, England
- MeSH terms
- Adult, England, Female, Humans, Immunization Schedule, Infant, Infant, Newborn, Male, Mortality, Population Surveillance, Vaccination, Whooping Cough, Diphtheria-Tetanus-Pertussis Vaccine, Incidence, Outcome Assessment, Health Care, Immunization Programs, Maternal Exposure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.